Asaf Shiloni, a veteran biotech founder and manager is the CEO of Kadimastem a clinical stage biotech company, that is creating cell therapy that enables the production of off-the-shelf cell-based products for the treatment of unmet medical needs such as ALS and a cure for Diabetes.
Avraham sat down with Asaf in the offices of Kadimastem to discuss how Kadimastem is creating and testing their innovative therapies, why Israeli startups are so successful, the role of patents in Kadimastem's business, tips for startup founders and much more.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
